| |
 |
Dr. Wing-kai Chan, MB BS, FRACP
Advisor, The Center of Excellence for Clinical Trial and Research, National Taiwan University Hospital
Clinical Trial Consortium Program Director, Taiwan National Research Program for Pharmaceuticals (NRPB)
Taipei, Taiwan |
|
| |
| Biography: |
|
| |
| I am the Taiwan Clinical Trial Consortium Program Director, Taiwan National Research Program for Pharmaceuticals (NRPB). This Consortium include all the major medical centers in Taiwan. |
| |
| I was the Founder and Director, The National Center of Excellence for Clinical Trial & Clinical Research, The National Taiwan University Hospital, Taiwan. |
| |
| I also have experience in international pharmaceutical companies as Senior Vice President, Head of Clinical Operations (Asia-Pacific) or Medical Director and participated in global new drug clinical development programs (including several multi-billion dollar drugs in cancers, infectious disease and other diseases) and Board of Management and Scientific Advisory Boards. |
| |
| Session: |
|
| |
| 21st November 2015 (Saturday) |
 |
13:00 - 13:25 |
|
| |
| Session III: Early Clinical Development in Asia |
| Phase 1 Clinical Trials in Taiwan |
| |
